Exacerbation of experimental asthma depends on IL-6 but not on IL-23 or ROR?t

L. Lunding (Borstel, Germany)

Source: International Congress 2017 – Animal models of asthma and allergies
Session: Animal models of asthma and allergies
Session type: Thematic Poster
Number: 1141
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
L. Lunding (Borstel, Germany). Exacerbation of experimental asthma depends on IL-6 but not on IL-23 or ROR?t. 1141

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Oral presentation: TLR-3 triggered aggravation of experimental asthma depends on IL-17
Source: Lung Science Conference 2013 - Early origins and mechanisms of chronic lung disease
Year: 2013

Serum TNF-a, IL-12 and IL-13 levels in severe bronchial asthma patients
Source: Eur Respir J 2004; 24: Suppl. 48, 353s
Year: 2004

Serum levels of IL-8, IL-10 and TNFα in severe allergic asthma
Source: Eur Respir J 2005; 26: Suppl. 49, 279s
Year: 2005

Interleukin-33 and Th2 cytokines correlate in acute asthma
Source: International Congress 2016 – Clinical and molecular studies in asthma
Year: 2016

Caspase-1 induces upstream Th2-cytokines IL-33 and TSLP and eosinophilia at viral induced asthma exacerbations
Source: International Congress 2016 – Asthma: mechanisms and biomarkers that promote clinical understanding
Year: 2016

IL-10 and IL-1ra mediates OVA-induced Th2 airway allergic response at short and long-term
Source: Annual Congress 2013 –The role of hormones and cytokines in lung injury
Year: 2013


Interleukin-4 and interleukin-5 are increased in asthma early in the course of the disease
Source: Eur Respir J 2007; 30: Suppl. 51, 139s
Year: 2007

Exacerbation of experimental asthma depends on IL-15 and NK cells
Source: International Congress 2017 – Animal models of asthma and allergies
Year: 2017

IL-37 ameliorates experimental asthma by inhibiting IL-1
Source: International Congress 2018 – Novel immunology-based therapies in asthma and COPD
Year: 2018



Concentration of IL-2, IL-4, IL-8 and TNF in blood serum and sputum in bronchial asthma and chronic obstructive pulmonary disease
Source: Annual Congress 2009 - Inflammation and airways
Year: 2009

Interleukin-10 (IL-10) level in sputum of asthmatic patients during exacerbation and after treatment
Source: Eur Respir J 2001; 18: Suppl. 33, 336s
Year: 2001

Effectiveness of photobiomodulation on the increase of Treg cells and IL-10 cytokine in an experimental model of chronic asthma
Source: International Congress 2019 – Modelling and monitoring of airway diseases
Year: 2019


IL-4, IFN-gamma and TNF-alpha levels in serum of patients with COPD, bronchial asthma and GERD
Source: Annual Congress 2012 - Inflammatory mechanisms in COPD
Year: 2012

Rhinovirus-induced cytokine production of circulating leukocytes is reduced in severe asthma
Source: Virtual Congress 2020 – New insight into the immunology of asthma and COPD
Year: 2020


LSC - 2019 - IL-4, IL-8, IL-13, IL-17, IL-33 serum levels changes in acute allergic asthma model
Source: International Congress 2019 – Novel insights from in vitro and in vivo models of lung disease
Year: 2019

Montelukast reduces Th2 type cytokines in induced sputum in mild asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 111s
Year: 2002

Production of IL-12 and IL-18 by alveolar macrophages in acute and chronic hypersensitivity pneumonitis
Source: Eur Respir J 2005; 26: Suppl. 49, 469s
Year: 2005

The production of IL-18, IL-12 and TNF-alpha by alveolar macrophages in sarcoidosis and hypersensitivity pneumonitis
Source: Eur Respir J 2003; 22: Suppl. 45, 177s
Year: 2003